Eye surgery showdown: device vs manual marking for sharper vision

NCT ID NCT07696468

First seen Jul 10, 2026 · Last updated Jul 16, 2026 · Updated 2 times

Summary

This trial tests whether a device called OcuLign, which automatically adjusts for eye rotation during SMILE surgery, corrects astigmatism better than the standard manual marking method. Adults aged 18 to 40 with stable myopia and astigmatism will have one eye treated with each method. The goal is to see which approach leaves less residual astigmatism three months after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
OcuLign-assisted cyclotorsion control (device procedure)
What this could lead to
If OcuLign proves better or equal to manual marking, it could become a standard tool for more precise astigmatism correction during SMILE surgery.
What could go wrong
This is a small, early-stage trial with only 52 participants. The improvement may be minimal, and results may not apply to all patients or surgeons.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Zhongshan Ophthalmic Center

    Guangzhou, Guangdong, 510060, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.